[Skip to Content]
[Skip to Content Landing]
Views 535
Citations 0
Comment & Response
July 4, 2017

Osteoporotic Fractures Associated With Dabigatran vs Warfarin

Author Affiliations
  • 1Department of Orthopaedic Surgery, Saitama Medical University, Saitama, Japan
JAMA. 2017;318(1):90-91. doi:10.1001/jama.2017.6908

To the Editor In a retrospective population-based cohort study including adult patients newly diagnosed with nonvalvular atrial fibrillation and subsequently prescribed dabigatran, a non-vitamin K antagonist oral anticoagulant (NOAC), or the vitamin K antagonist warfarin, Mr Lau and colleagues reported lower osteoporotic hip plus vertebral fracture risk among dabigatran vs warfarin users (incidence rate ratio [IRR], 0.38; 95% CI, 0.22 to 0.66).1 This is an important finding that requires careful interpretation.

First Page Preview View Large
First page PDF preview
First page PDF preview